Chemical Compound

RIFAMYCIN B

CAS Registry Number 13929-35-6
RIFAMYCIN B chemical structure
Primary Record

RIFAMYCIN B

In stock
6,721 g
Purity
99.6 %
CAS
13929-35-6

Compound Identifiers & Properties

CAS
13929-35-6
PubChem CID
5459948
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)OCC(=O)O)/C
Canonical SMILES
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(OCC(=O)O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

Names & Synonyms

  • RIFAMYCIN B
  • Nancimycin
  • Nacimycin
  • Rifomycin B
  • Rifamycin B CRS
  • 4-O-(Carboxymethyl)rifamycin
  • Rifaximin EP Impurity B
  • Rifomycin B (6CI)
  • 8DDB535DJI
  • UNII-8DDB535DJI
  • RefChem:179425
  • GlyTouCan:G26249CQ
  • Rifamycin, 4-O-(carboxymethyl)-
  • RIFAMYCIN B [MI]
  • 13929-35-6
  • C39H49NO14
  • CHEBI:17876
  • SCHEMBL437936
  • 4-O-(Carboxymethyl)-Rifamycin
  • DTXSID901037384
  • SCHEMBL30825668
  • EINECS 237-697-8
  • SQTCRTQCPJICLD-KTQDUKAHSA-N
  • DTXCID801521425
  • NSC 145604
  • NSC-145604
  • G26249CQ
  • NCI 145-604
  • 8247AH
  • BBF-02631
  • LMPK05000003
  • STL564327
  • AKOS030489430
  • C39-H49-N-O14
  • o[2,1-b]furan-9-yl]oxy}acetic acid
  • ZINC169633670
  • CID5459948
  • FR178810
  • RIFAXIMIN IMPURITY B [EP IMPURITY]
  • C01848
  • H55548
  • RIFAMYCIN SODIUM IMPURITY A [EP IMPURITY]
  • Q27102689
  • Acetic acid, ((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)-oxy)-, 21-acetate
  • 2-(acetoxy-tetrahydroxy-methoxy-heptamethyl-dioxo-[?]yl)oxyacetic acid
  • conta-1(28),2,4,9,19,21,25(29),26-octaen-27-yl]oxy}acetic acid
  • ((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(ACETYLOXY)-5,6,17,19-TETRAHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,11-DIOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-9-YL)ACETIC ACID
  • [(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-acetyloxy-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yloxy]acetic acid
  • {[(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphth
  • 2-(((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-27-yl)oxy)acetic acid
  • 2-[[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetoxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-yl]oxy]acetic acid
  • 2-[[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-yl]oxy]acetic acid
  • 2-{[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-(acetyloxy)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]tria
  • 237-697-8
  • Acetic acid, [(1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-, 21-acetate
  • Rifamycin, 4-O-(carboxymethyl)-; Acetic acid, [(1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-, 21-acetate (7CI,8CI); Rifomycin B (6CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; NSC 145604; Nancimycin; Rifamycin B; Rifaximin Imp B (EP)